Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 158Thoracic 140Dermatologic 133Genitourinary 123Head & Neck 65CNS 48Lymphoid 45Gynecologic 37Other solid neoplasm 32Sarcoma 28Breast 27Tumor-Agnostic 20Endocrine 17Other hematologic neoplasm 14Plasma cell 9NET 7Myeloid 6Other neoplasm 2Classical hematology 1

Conditions

Tobacco Smoking 1Precancerous Conditions 1Malignant Neoplasms of Digestive Organs 1Head and Neck Neoplasms 1

Interventions

fludarabine 5Educational Status 5fludarabine phosphate 4Whole-Body Irradiation 4Mycophenolic Acid 4Methods 4Melphalan 4Magnetic Resonance Spectroscopy 4Early Intervention, Educational 4Cyclophosphamide 4Busulfan 4Biopsy 4Taxes 3Tacrolimus 3Specimen Handling 3Peripheral Blood Stem Cell Transplantation 3Paclitaxel 3Interviews as Topic 3venetoclax 2Sirolimus 2Patient Reported Outcome Measures 2Nivolumab 2Mesna 2Health Promotion 2Colposcopy 2Cisplatin 2Aminolevulinic Acid 2Albumin-Bound Paclitaxel 2toripalimab 1tirbanibulin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nivolumab × Other neoplasm × 1 year × Clear all
NCT03347838 2025-12-12

Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers

University of Colorado, Denver

Phase 2 Active not recruiting
19 enrolled 10 charts
Head & NeckOther neoplasm

Tobacco Smoking, Head and Neck Neoplasms, Precancerous Conditions

NCT05934331 2025-09-12

A LM-302 Combination With Other Anti-Tumor Therapies Phase ll Study

LaNova Medicines Limited

Phase 2 Recruiting
276 enrolled
Other neoplasm

Malignant Neoplasms of Digestive Organs

Data powered by HemOnc (CC BY 4.0) Colophon âš¡